Global Health Concerns: Mpox Outbreaks, Innovations, and Regulatory Challenges

Current health news highlights the UN's appeal for aid to combat mpox in Africa, Thailand confirming a new mpox strain case, and notable updates on Neuralink's trials. Other stories include Argentina ruling out a suspected mpox case, Liquidia's regulatory challenge, and the explosion in an Indian pharma factory.

Following a summary of current health news briefs.

The UN's International Organisation for Migration (IOM) has issued an $18.5 million funding appeal to provide healthcare in response to the mpox outbreak spanning East, Horn, and Southern Africa. This region, inclusive of vulnerable migrant and displaced communities, remains significantly impacted.

This Thursday, Thailand confirmed its second mpox case of the clade 1b virus strain outside Africa. The profile involves a 66-year-old European male who had recently arrived from Africa.

Neuralink, Elon Musk's brain technology startup, announced that its second trial implant operated successfully without issues faced in the first trial. The device aims to assist paralyzed patients in digital interactions.

(With inputs from agencies.)